1
|
Commins N, Subhaharan D, Kurup R, Wickremeratne T, Mitchell J, Elmes J, Braund A, Funakoshi N, Langton J, Leschke P, O'Beirne J. Indications and outcomes of transjugular intrahepatic portosystemic shunt insertion in two regional Australian hepatology centres. Intern Med J 2024. [PMID: 38654627 DOI: 10.1111/imj.16384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2023] [Accepted: 03/13/2024] [Indexed: 04/26/2024]
Abstract
BACKGROUND Transjugular intrahepatic portosystemic shunt (TIPS) is an important therapy for complications of portal hypertension but remains underutilised in regional settings. AIMS The aim of this study is to explore the demographics, indications, outcomes and complications in patients undergoing TIPS in two regional hepatology centres. METHODS Retrospective analysis was undertaken of all patients undergoing TIPS at two regional centres between January 2017 and March 2023. The primary outcome measures were efficacy and complications of TIPS. Patient demographics (such as age, baseline liver severity scores and aetiology of liver disease) and indications for TIPS are detailed. RESULTS Forty-eight patients underwent TIPS. Median age was 56 years (interquartile range (IQR): 46-65). The most common indications for TIPS were refractory ascites (n = 17) and failure of secondary prophylaxis of variceal bleeding (n = 13). Cumulative survival at 3 months and 1 year was 93% and 77% respectively. There was no significant difference in outcomes based on TIPS indication. The median number of paracenteses in patients undergoing TIPS for refractory ascites 1 year pre- and post-TIPS were 10 (IQR: 4.5-16) and 2 (IQR: 0-4) respectively (P < 0.001). There were no procedure-related deaths. Inpatient management of liver disease complications had a mean cost of $32 874.67 (SEM: 7779) in 1 year pre-TIPS compared with $12 304.70 (SEM: 3531.1) in 1 year post-TIPS (P < 0.001). CONCLUSIONS TIPS is a safe and effective treatment to reduce complications of portal hypertension and can be performed successfully in the regional setting.
Collapse
Affiliation(s)
- Natalie Commins
- Department of Hepatology, Sunshine Coast University Hospital, Sunshine Coast, Queensland, Australia
| | - Deloshaan Subhaharan
- Department of Hepatology, Sunshine Coast University Hospital, Sunshine Coast, Queensland, Australia
- Department of Hepatology, Gold Coast University Hospital, Southport, Queensland, Australia
| | - Rajiv Kurup
- Department of Hepatology, Sunshine Coast University Hospital, Sunshine Coast, Queensland, Australia
| | - Tehara Wickremeratne
- Department of Hepatology, Sunshine Coast University Hospital, Sunshine Coast, Queensland, Australia
| | - Jonathan Mitchell
- Department of Hepatology, Sunshine Coast University Hospital, Sunshine Coast, Queensland, Australia
| | - Julie Elmes
- Department of Hepatology, Gold Coast University Hospital, Southport, Queensland, Australia
| | - Alicia Braund
- Department of Hepatology, Gold Coast University Hospital, Southport, Queensland, Australia
| | - Natalie Funakoshi
- Department of Hepatology, Gold Coast University Hospital, Southport, Queensland, Australia
| | - Jonathan Langton
- Department of Interventional Radiology, Sunshine Coast University Hospital, Sunshine Coast, Queensland, Australia
| | - Paul Leschke
- Department of Interventional Radiology, Sunshine Coast University Hospital, Sunshine Coast, Queensland, Australia
| | - James O'Beirne
- Department of Hepatology, Sunshine Coast University Hospital, Sunshine Coast, Queensland, Australia
- University of the Sunshine Coast, Sunshine Coast, Queensland, Australia
| |
Collapse
|
2
|
Commins N, Subhaharan D, Dettrick A, Patrick D. Mercaptopurine-induced Sweet's syndrome. BMJ Case Rep 2024; 17:e259278. [PMID: 38417937 PMCID: PMC10900376 DOI: 10.1136/bcr-2023-259278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/01/2024] Open
Abstract
Sweet's syndrome is an acute febrile neutrophilic dermatosis. Drug-induced Sweet's syndrome typically occurs soon after drug administration, with rapid resolution of symptoms with cessation of the offending agent. We report a man in his early 40s who presented with fever and widespread erythematous rash on a background of recently diagnosed mild stricturing ileal Crohn's disease. He was commenced on 6-mercaptopurine 12 days before presentation. Skin biopsy demonstrated diffuse infiltration of neutrophils in the upper dermis, dermal oedema, eosinophils and fibrin deposition. Symptoms rapidly improved with cessation of 6-mercaptopurine without requiring systemic corticosteroids.
Collapse
Affiliation(s)
- Natalie Commins
- Department of Gastroenterology, Sunshine Coast University Hospital, Birtinya, Queensland, Australia
| | - Deloshaan Subhaharan
- Department of Gastroenterology, Sunshine Coast University Hospital, Birtinya, Queensland, Australia
| | - Andrew Dettrick
- Department of Pathology, Pathology Queensland, Birtinya, Queensland, Australia
| | - Desmond Patrick
- Department of Gastroenterology, Sunshine Coast University Hospital, Birtinya, Queensland, Australia
| |
Collapse
|
3
|
Zaka A, Mridha N, Subhaharan D, Jones M, Niranjan S, Mohsen W, Ramaswamy PK. Inflammatory bowel disease patients have an increased risk of acute coronary syndrome: a systematic review and meta-analysis. Open Heart 2023; 10:e002483. [PMID: 37940332 PMCID: PMC10632902 DOI: 10.1136/openhrt-2023-002483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/12/2023] [Accepted: 10/03/2023] [Indexed: 11/10/2023] Open
Abstract
OBJECTIVES Systemic inflammation is increasingly being recognised as a possible mechanism for acute arterial thrombotic events, including acute coronary syndrome (ACS). Despite this, there is conflicting data on the risk of ACS in patients with inflammatory bowel disease (IBD). We performed a contemporary systematic review and meta-analysis to identify the risk of ACS in patients with IBD. METHODS PubMed, MEDLINE, EMBASE, CENTRAL and Web of Science were searched up to 27 October 2022. Multivariable-adjusted or propensity matched studies with a non-IBD control cohort were included. HRs were pooled using a random-effects model. Subgroup and sensitivity analyses were conducted in order to explore sources of heterogeneity. RESULTS Twelve retrospective cohort studies were included (225 248 IBD patients). Patients with IBD were associated with an increased risk of ACS in both adjusted (HR 1.23; 95% CI 1.08 to 1.41) and unadjusted analyses (HR 1.50; 95% CI 1.16 to 1.92). Substantial heterogeneity was observed (i2=88, p=0.002 and i2=98%, p=0.002, respectively). Subgroup analysis of age revealed a greater association of ACS in IBD patients <40 years of age (relative HR 1.50; 95 CI 1.15 to 1.96). CONCLUSION Patients with IBD demonstrated an independently increased risk of ACS. Prospective studies are required to explore the relationship with disease activity and duration, concomitant medication use and angiographic characteristics and outcomes. PROSPERO REGISTRATION NUMBER CRD42022367846.
Collapse
Affiliation(s)
- Ammar Zaka
- Department of Cardiology, Gold Coast University Hospital, Southport, Queensland, Australia
- Faculty of Medicine, Griffith University, Nathan, Queensland, Australia
| | - Naim Mridha
- Department of Cardiology, The Prince Charles Hospital, Chermside, Queensland, Australia
- Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia
| | - Deloshaan Subhaharan
- Department of Digestive Health, Gold Coast University Hospital, Southport, Queensland, Australia
- Bond University, Robina, Queensland, Australia
| | - Mark Jones
- Bond University, Robina, Queensland, Australia
| | - Selvanayagam Niranjan
- Department of Cardiology, Gold Coast University Hospital, Southport, Queensland, Australia
- Bond University, Robina, Queensland, Australia
| | - Waled Mohsen
- Department of Digestive Health, Gold Coast University Hospital, Southport, Queensland, Australia
| | - Pradeep K Ramaswamy
- Department of Digestive Health, Gold Coast University Hospital, Southport, Queensland, Australia
| |
Collapse
|
4
|
Subhaharan D, Ramaswamy PK, Willmann L, Moattar H, Bhullar M, Ishaq N, Dorrington A, Shukla D, McIvor C, Edwards J, Mohsen W. Older adults with acute severe ulcerative colitis have similar steroid non-response and colectomy rates as younger adults. World J Gastroenterol 2023; 29:2469-2478. [PMID: 37179589 PMCID: PMC10167901 DOI: 10.3748/wjg.v29.i16.2469] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/15/2022] [Revised: 02/11/2023] [Accepted: 03/24/2023] [Indexed: 04/24/2023] Open
Abstract
BACKGROUND There is paucity of data on outcomes of acute severe ulcerative colitis (ASUC) in older adults (≥ 60 years of age). AIM To assess steroid non-response rates during the index admission for ASUC in older adults. Secondary outcomes were response to medical rescue therapy and colectomy rates; at index admission, 3 and 12 mo. METHODS This retrospective multicentre cohort study included ASUC admissions who received intravenous steroids between January 2013 and July 2020 at two tertiary hospitals. Electronic medical records were reviewed to collect clinical, biochemical, and endoscopic data. A modified Poisson regression model was used for analysis. RESULTS Of 226 ASUC episodes, 45 (19.9%) occurred in patients ≥ 60 years of age. Steroid non-response rates were comparable in older adults and patients < 60 years of age [19 (42.2%) vs 85 (47%), P = 0.618, crude risk ratio (RR) = 0.89 [95% confidence interval (CI): 0.61-1.30], adjusted RR = 0.99 (0.44-2.21). Rates of response to medical rescue therapy in older adults was comparable to the younger cohort [76.5% vs 85.7%, P = 0.46, crude RR = 0.89 (0.67-1.17)]. Index admission colectomy [13.3% vs 10.5%, P = 0.598, crude RR = 1.27 (0.53-2.99), adjusted RR = 1.43 (0.34-6.06)], colectomy at 3 mo [20% vs 16.6%, P = 0.66, crude RR = 1.18 (0.61-2.3), adjusted RR = 1.31 (0.32-0.53)] and colectomy at 12 mo [20% vs 23.2%, P = 0.682, crude RR = 0.85 (0.45-1.57), adjusted RR = 1.21 (0.29-4.97)], were similar between the two groups. CONCLUSION In older adults with ASUC, the steroid non-response rate, response to medical rescue therapy, and colectomy rate at index admission, 3 and 12 mo is similar to patients less than 60 years of age.
Collapse
Affiliation(s)
- Deloshaan Subhaharan
- Department of Digestive Diseases, Gold Coast University Hospital, Gold Coast 4215, Queensland, Australia
| | | | - Laura Willmann
- Department of Digestive Diseases, Gold Coast University Hospital, Gold Coast 4215, Queensland, Australia
| | - Hadi Moattar
- Department of Digestive Diseases, Gold Coast University Hospital, Gold Coast 4215, Queensland, Australia
| | - Maneesha Bhullar
- Department of Digestive Diseases, Gold Coast University Hospital, Gold Coast 4215, Queensland, Australia
| | - Naveed Ishaq
- Department of Digestive Diseases, Gold Coast University Hospital, Gold Coast 4215, Queensland, Australia
| | - Alexander Dorrington
- Department of Digestive Diseases, Gold Coast University Hospital, Gold Coast 4215, Queensland, Australia
| | - Dheeraj Shukla
- Department of Digestive Diseases, Gold Coast University Hospital, Gold Coast 4215, Queensland, Australia
| | - Carolyn McIvor
- Department of Gastroenterology, Logan Hospital, Logan 4131, Queensland, Australia
| | - John Edwards
- Department of Digestive Diseases, Gold Coast University Hospital, Gold Coast 4215, Queensland, Australia
| | - Waled Mohsen
- Department of Digestive Diseases, Gold Coast University Hospital, Gold Coast 4215, Queensland, Australia
| |
Collapse
|
5
|
Adams A, Gupta V, Mohsen W, Chapman TP, Subhaharan D, Kakkadasam Ramaswamy P, Kumar S, Kedia S, McGregor CG, Ambrose T, George BD, Palmer R, Brain O, Walsh A, Ahuja V, Travis SPL, Satsangi J. Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response. Gut 2023; 72:433-442. [PMID: 36171080 DOI: 10.1136/gutjnl-2022-327533] [Citation(s) in RCA: 10] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/05/2022] [Accepted: 08/27/2022] [Indexed: 12/08/2022]
Abstract
OBJECTIVES We aimed to determine whether changes in acute severe colitis (ASC) management have translated to improved outcomes and to develop a simple model predicting steroid non-response on admission. DESIGN Outcomes of 131 adult ASC admissions (117 patients) in Oxford, UK between 2015 and 2019 were compared with data from 1992 to 1993. All patients received standard treatment with intravenous corticosteroids and endoscopic disease activity scoring (Ulcerative Colitis Endoscopic Index of Severity (UCEIS)). Steroid non-response was defined as receiving medical rescue therapy or surgery. A predictive model developed in the Oxford cohort was validated in Australia and India (Gold Coast University Hospital 2015-2020, n=110; All India Institute of Medical Sciences, New Delhi 2018-2020, n=62). RESULTS In the 2015-2019 Oxford cohort, 15% required colectomy during admission vs 29% in 1992-1993 (p=0.033), while 71 (54%) patients received medical rescue therapy (27% ciclosporin, 27% anti-tumour necrosis factor, compared with 27% ciclosporin in 1992-1993 (p=0.0015). Admission C reactive protein (CRP) (false discovery rate, p=0.00066), albumin (0.0066) and UCEIS scores (0.015) predicted steroid non-response. A four-point model was developed involving CRP of ≥100 mg/L (one point), albumin of ≤25 g/L (one point), and UCEIS score of ≥4 (1 point) or ≥7 (2 points). Patients scoring 0, 1, 2, 3 and 4 in the validation cohorts had steroid response rates of 100, 75.0%, 54.9%, 18.2% and 0%, respectively. Scoring of ≥3 was 84% (95% CI 0.70 to 0.98) predictive of steroid failure (OR 11.9, 95% CI 10.8 to 13.0). Colectomy rates in the validation cohorts were were 8%-11%. CONCLUSIONS Emergency colectomy rates for ASC have halved in 25 years to 8%-15% worldwide. Patients who will not respond to corticosteroids are readily identified on admission and may be prioritised for early intensification of therapy.
Collapse
Affiliation(s)
- Alex Adams
- Translational Gastroenterology Unit, University of Oxford, Oxford, UK
| | - Vipin Gupta
- Translational Gastroenterology Unit, University of Oxford, Oxford, UK.,Department of Gastroenterology, North Bristol NHS Trust, Bristol, UK
| | - Waled Mohsen
- Translational Gastroenterology Unit, University of Oxford, Oxford, UK.,Digestive Diseases Unit, Gold Coast University Hospital, Southport, Queensland, Australia
| | - Thomas P Chapman
- Translational Gastroenterology Unit, University of Oxford, Oxford, UK.,Department of Gastroenterology, St Richard's and Worthing Hospitals, University Hospitals Sussex NHS Foundation Trust, West Sussex, UK
| | - Deloshaan Subhaharan
- Digestive Diseases Unit, Gold Coast University Hospital, Southport, Queensland, Australia
| | | | - Sudheer Kumar
- Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India
| | - Saurabh Kedia
- Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India
| | | | - Tim Ambrose
- Translational Gastroenterology Unit, University of Oxford, Oxford, UK
| | - Bruce D George
- Translational Gastroenterology Unit, University of Oxford, Oxford, UK
| | - Rebecca Palmer
- Translational Gastroenterology Unit, University of Oxford, Oxford, UK
| | - Oliver Brain
- Translational Gastroenterology Unit, University of Oxford, Oxford, UK
| | - Alissa Walsh
- Translational Gastroenterology Unit, University of Oxford, Oxford, UK
| | - Vineet Ahuja
- Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India
| | - Simon P L Travis
- Translational Gastroenterology Unit, University of Oxford, Oxford, UK
| | - Jack Satsangi
- Translational Gastroenterology Unit, University of Oxford, Oxford, UK
| |
Collapse
|
6
|
Mridha N, Subhaharan D, Niranjan S, Rashid MK, Psaltis P, Singh K. A meta-analysis of randomized controlled trials to compare long-term clinical outcomes of bioabsorbable polymer and durable polymer drug-eluting stents. Eur Heart J Qual Care Clin Outcomes 2019; 5:105-113. [PMID: 30032294 DOI: 10.1093/ehjqcco/qcy036] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/21/2018] [Revised: 07/13/2018] [Accepted: 07/18/2018] [Indexed: 11/13/2022]
Abstract
AIMS The durable polymer (DP) of a drug-eluting stent (DES) serves no function once drug elution is complete. To ascertain the benefits of bioabsorbable polymer (BP) over DP-DESs requires a longer follow-up period, to overcome the time taken for polymer absorption. The primary aim of this meta-analysis was to compare the safety and efficacy of BP-DES with the DP-DES over mid (2 years) to long-term (3-5 years) follow-up. METHODS AND RESULTS A thorough computer-based search was performed using Ovid MEDLINE, EMBASE, Google Scholar, and PubMed databases. We only included randomized controlled studies comparing clinical outcomes between BP-DESs and DP-DESs. Only studies where data were available for a minimum of 2 years were included. A separate analysis of 2-year outcomes and 3- to 5-year outcomes were conducted. Data from 6 and 8 studies were included in 3- to 5-year and 2-year follow-up, respectively. There were no differences between stent groups in cardiac mortality, stent thrombosis (ST), target lesion revascularization, target vessel failure, and reinfarction rates for either 2-year or 3- to 5-year follow-up. Subgroup analysis according to strut thickness (<100 µm, >100 µm) of BP-DES demonstrated similar results. The analyses of ST and very late ST favoured BP-DESs but did not reach statistically significant level. CONCLUSION There were no differences in clinical outcomes between BP-DESs and DP-DESs over mid- and long-term follow-up.
Collapse
Affiliation(s)
- Naim Mridha
- Department of Cardiology, Gold Coast University Hospital, 1 Hospital Blvd Southport, QLD, Australia.,Department of Medicine, Griffith University, Parklands Dr, Southport, QLD, Australia.,School of medicine, Bond University, 14 University Dr, Robina, QLD, Australia
| | - Deloshaan Subhaharan
- Department of Cardiology, Gold Coast University Hospital, 1 Hospital Blvd Southport, QLD, Australia.,School of medicine, Bond University, 14 University Dr, Robina, QLD, Australia
| | - Selvanayagam Niranjan
- Department of Cardiology, Gold Coast University Hospital, 1 Hospital Blvd Southport, QLD, Australia.,Department of Medicine, Griffith University, Parklands Dr, Southport, QLD, Australia.,School of medicine, Bond University, 14 University Dr, Robina, QLD, Australia
| | - Mohammed K Rashid
- Department of Medicine, Mc Master University, 1280 Main St W, Hamilton, ON, Canada
| | - Peter Psaltis
- Department of medicine, University of Adelaide, North Terrace, Adelaide, SA, Australia.,Department of Medicine, The South Australian Health and Medical Research Institute, North Terrace, Adelaide, SA, Australia
| | - Kuljit Singh
- Department of Cardiology, Gold Coast University Hospital, 1 Hospital Blvd Southport, QLD, Australia.,Department of Medicine, Griffith University, Parklands Dr, Southport, QLD, Australia.,School of medicine, Bond University, 14 University Dr, Robina, QLD, Australia.,Department of medicine, University of Adelaide, North Terrace, Adelaide, SA, Australia
| |
Collapse
|
7
|
Subhaharan D, Mridha N, Singh K. Clinical Benefits of Prolonged DAPT Following Complex Percutaneous Coronary Intervention. Heart Lung Circ 2019. [DOI: 10.1016/j.hlc.2019.06.592] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
8
|
Singh K, Subhaharan D, Mridha N. P5525A meta-analysis of randomised controlled trials to compare safety and efficacy of everolimus/sirolimus bioabsorbable polymer with second-generation durable-polymer drug eluting stents. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p5525] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- K Singh
- University of Adelaide, Queen Elizabeth Hospital, Adelaide, Australia
| | | | - N Mridha
- Gold Coast Hospital, Gold Coast, Australia
| |
Collapse
|
9
|
Singh K, Subhaharan D, Mridha N. P5529A five-year follow-up of randomised studies comparing outcomes between bioabsorbable-polymer and durable-polymer drug-eluting stents: systematic review and meta-analysis. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p5529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- K Singh
- Gold Coast Hospital, Gold Coast, Australia
| | | | - N Mridha
- Gold Coast Hospital, Gold Coast, Australia
| |
Collapse
|